Please login to read the full article.
Scrip Regulatory Affairs
New Swiss requirements on submissions for generics and products with known APIs get industry thumbs up
10 October 2011
Alan Chalmers
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
- Applying for multinational EU trials can be faster via voluntary harmonisation procedure
- ICH to clarify E3 guideline on clinical study reports and alignment with CTD
- UK consults on transposing EU pharmacovigilance rules into national law
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
